SCHEMBL19112092

SCHEMBL19112092

CC(C)N(C)Cc1ccc(-c2ccccn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP19A1 P11511 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CCNE1 P24864 4/20 0.42
CDK2 P24941 4/20 0.42
CDK5 Q00535 4/20 0.42
KCNH2 Q12809 2/20 0.41
NR1I2 O75469 1/20 0.41
NMBR P28336 1/20 0.41
GRPR P30550 1/20 0.41
BRS3 P32247 1/20 0.41
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA5A P35218 5/20 0.41
CA9 Q16790 5/20 0.41
CA5B Q9Y2D0 5/20 0.41
CHRM2 P08172 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112162 0.83 TAAR1 (0.58) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL22651951 0.78 CYP1A2 (0.45) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL28363524 0.77 ADRA2B (0.46) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL3239427 0.77 JAK1 (0.44) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL10260862 0.77 CYP1A2 (0.50) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL2179770 0.76 CA12 (0.41) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL20904180 0.76 CA12 (0.55) CA12CA1CA2CA5ACA9
SCHEMBL21127229 0.75 ADRA2B (0.50) KCNH2ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL6840443 0.74 CYP1A2 (0.59) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL31211649 0.74 CYP1A2 (0.59) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2664619-B1 Purine derivatives as tools for screening anti-Alzheimer compounds MANROS THERAPEUTICS (FR) 2017-07-12 EP disclosed